MEDICLIN Aktiengesellschaft (MED) Fair Value & Analysis
Healthcare · DE · Market cap €178M
Fair value as of: Jun 25, 2026
From 25 valuation models · updated 4 days ago
Fair value updated Jun 25, 2026 — revised from €11.80 to €9.12 (−22.7%) since Jun 24, 2026. Share price +5.9% over the past month.
Price vs Fair Value (12 months)
12‑month range €2.86 – €4.22 · fair‑value band €6.84 – €11.40 · the €3.98 price screens below the €9.12 fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
MEDICLIN Aktiengesellschaft (MED) currently trades at €3.98, while our model-based Fair Value estimate is €9.12 — implying the stock looks roughly 129.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, MEDICLIN Aktiengesellschaft generated revenue of €810M at a net margin of 3.6%. Revenue grew 5.0% year over year. It earns a return on equity of 12.4%. Net debt stands at €319M. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
About the company
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments. It offers medical services in the areas of neurology; psychosomatics; orthopedics; internal medicine; cardiology; oncology; geriatrics; psychiatry; otorhinolaryngology; cardiac medicine; rheumatology; gynecology; trauma, heart, and general surgeries; urology; and others. The company also provides services in the areas of ENT and acute outpatient services. It owns 31 clinical facilities, rehabilitation care, 6 nursing care facilities, and 9 medical care centers in 11 German federal states. The company was incorporated in 1994 and is headquartered in Offenburg, Germany.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
MEDICLIN Aktiengesellschaft reported revenue of €784M in FY2025 versus €673M in FY2021, a compound +3.9%/yr. Reported net income was €25.5M in FY2025, compounding +104.4%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| 5225 5225 | 8.71 MYR | 4.87 MYR | -44% |
| IHHHF IHHHF | $1.71 | $1.17 | -32% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is MEDICLIN Aktiengesellschaft (MED) undervalued?
What is the fair value of MED?
What is the quality score of MED?
What is the revenue of MEDICLIN Aktiengesellschaft (MED)?
What is the net profit margin of MED?
Does MEDICLIN Aktiengesellschaft pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.